Vanderbilt Ingram Cancer Center
-
VICC hosts cancer researchers during annual retreat
The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center. Read MoreMay 23, 2013
-
West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement
Kirkland Cancer Center Leaders of West Tennessee Healthcare (WTH) and Vanderbilt University Medical Center today announced an academic affiliation agreement which further establishes a collaborative relationship between the two institutions, now for the creation of new cancer programs in West Tennessee. The new agreement creates a… Read MoreMay 21, 2013
-
Arteaga to lead major new cancer research initiatives
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center. Read MoreMay 9, 2013
-
Dual-action enzyme protects esophagus
An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus. Read MoreMay 9, 2013
-
Budding songwriters needed for Songs from the Heart Concert
Cancer patients, family members and cancer health care workers all have a story to tell. Those who want to share their stories through music are invited to enroll in a songwriting workshop for the upcoming May 17 Songs from the Heart Concert. The annual songwriting workshop and… Read MoreMay 2, 2013
-
Moses receives AACR’s lifetime achievement in research award
Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, acting chair of Cancer Biology and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. Read MoreApr 11, 2013
-
Cancer studies reveal new genetic variants
The future of cancer is becoming clearer. And it’s not looking so good for cancer. Read MoreApr 4, 2013
-
Nobel laureate Hartwell set for Discovery Lecture
Nobel laureate Lee Hartwell, Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, April 11. Read MoreApr 4, 2013
-
VU’s Arteaga to lead American Association for Cancer Research
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Read MoreApr 4, 2013
-
Moses named to inaugural class of AACR fellows
Harold L. (Hal) Moses, M.D., professor and acting chair of Cancer Biology and professor of Medicine and Pathology, Microbiology and Immunology, has been named to the first class of the Fellows of the American Association for Cancer Research (AACR) Academy. Read MoreMar 28, 2013
-
Foundation lauds graduate student’s melanoma research
Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. Read MoreMar 28, 2013
-
VU to serve as host site for ACS cancer prevention study
Most cancers are sporadic, which means that physicians don’t have enough clues to determine what caused an individual’s disease. Read MoreMar 28, 2013
-
Study finds high soy diet before lung cancer diagnosis improves survival
A new study by researchers at Vanderbilt University Medical Center and the Shanghai Cancer Institute found women who ate more soy food prior to a diagnosis of lung cancer lived longer than those who consumed less. The study, conducted in Shanghai, China, was published in the March 25 issue of the Journal of Clinical Oncology. Read MoreMar 26, 2013
-
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. Read MoreMar 21, 2013
-
Patient’s cancer journey inspires fund for research
There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. Read MoreMar 21, 2013
-
Study offers insights into gastric cancer prevention
Gastric cancer is the second leading cause of cancer death worldwide, with a particular burden in Latin America and eastern Asia. Read MoreFeb 28, 2013
-
Vaccination key to preventing HPV-related cancers
Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute. Read MoreFeb 28, 2013
-
New fluorescing agent shines light on bladder cancer cells
Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder. Read MoreFeb 28, 2013
-
Factor CITED in pediatric liver cancer
Vanderbilt researchers report that they have found a factor involved in the persistence of embryonic cells implicated in childhood liver cancer. Read MoreFeb 20, 2013
-
‘Champions’ wanted for nationwide cancer prevention study
What if you could prevent even one family member from hearing the words, “You have cancer”? The American Cancer Society is seeking volunteers from the Vanderbilt community to become “champions” who spread the word about a historic cancer research study coming to Langford Auditorium April 25. Many… Read MoreFeb 6, 2013